In the renal cell carcinoma (RCC) group, the greatest increase is seen in RCC without comorbid obesity or smoking, as seen with upregulation of PTGS1, which aligns with current literature studying that COX-1 expression correlates with clinicopathological features of RCC. This evidence concerns the gene PTGS1 and obesity disorder.